Arterial thromboembolism associated with COVID-19 and elevated D-dimer levels

The novel coronavirus 2019 (SARS-CoV-2) was first identified in January 2020 and has since evolved into a pandemic affecting >200 countries. The severity of presentation is variable and carries a mortality between 1% and 3%. We continue to learn about the virus and the resulting acute respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Karan, Barfield, Michael E., Pezold, Michael L., Sadek, Mikel, Cayne, Neal S., Lugo, Joanelle, Maldonado, Thomas S., Berland, Todd L., Rockman, Caron B., Jacobowitz, Glenn R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297695/
https://www.ncbi.nlm.nih.gov/pubmed/32704579
http://dx.doi.org/10.1016/j.jvscit.2020.06.001
Descripción
Sumario:The novel coronavirus 2019 (SARS-CoV-2) was first identified in January 2020 and has since evolved into a pandemic affecting >200 countries. The severity of presentation is variable and carries a mortality between 1% and 3%. We continue to learn about the virus and the resulting acute respiratory illness and hypercoagulability; however, much remains unknown. In our early experience in a high-volume center, we report a series of four cases of acute peripheral artery ischemia in patients with COVID-19 in the setting of elevated D-dimer levels.

Ejemplares similares